News

Sanofi, Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas

Sanofi will receive exclusive worldwide rights to develop, manufacture and commercialize infectious disease vaccines using Translate Bio technology

Read More

Jun 25, 2020

By : Team ABLE

South Korea’s Genexine to initiate phase 1 trials of DNA vaccine against COVID-19

Genexine received approval for clinical phase 1/2a of GX-19, a DNA vaccine against COVID-19, by the country’s Ministry of Food and Drug Safety.

Read More

Jun 25, 2020

By : Team ABLE

NCASR starts crash course on molecular diagnosis of infectious diseases focusing on COVID 19

JNCASR has embarked upon a campaign by establishing a state-of-the-art diagnostic training facility to train personnel in real-time PCR for COVID-19.

Read More

Jun 25, 2020

By : Team ABLE

Deaths from HIV, TB, Malaria could almost double in 12 months unless urgent action is taken: warns Global Fund COVID-19 report

Aside from the direct toll of COVID-19, which could be catastrophic in the most vulnerable countries, estimates suggest deaths from HIV, TB and malaria could as much as double.

Read More

Jun 25, 2020

By : Team ABLE

C-CAMP, Applied Materials India assist biotech startups to increase availability of indigenous medical supplies during COVID-19

Two startups, Coeo Labs and Biomoneta, were chosen by C-CAMP’s COVID-19 Innovations Deployment Accelerator (C-CIDA).

Read More

Jun 24, 2020

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights